RAPT Therapeutics Inc (NASDAQ: RAPT) kicked off on Tuesday, up 21.67% from the previous trading day, before settling in for the closing price of $8.72. Over the past 52 weeks, RAPT has traded in a range of $5.67-$30.60.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -10.10% over the last five years. While this was happening, its average annual earnings per share was recorded 89.06%. With a float of $15.74 million, this company’s outstanding shares have now reached $16.50 million.
The firm has a total of 68 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
RAPT Therapeutics Inc (RAPT) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of RAPT Therapeutics Inc is 4.79%, while institutional ownership is 51.79%.
RAPT Therapeutics Inc (RAPT) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.79 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 89.06% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 53.09% during the next five years compared to -10.10% drop over the previous five years of trading.
RAPT Therapeutics Inc (NASDAQ: RAPT) Trading Performance Indicators
Take a look at RAPT Therapeutics Inc’s (RAPT) current performance indicators. Last quarter, stock had a quick ratio of 21.11.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -19.25, a number that is poised to hit -0.76 in the next quarter and is forecasted to reach -3.61 in one year’s time.
Technical Analysis of RAPT Therapeutics Inc (RAPT)
Analysing the last 5-days average volume posted by the [RAPT Therapeutics Inc, RAPT], we can find that recorded value of 0.19 million was better than the volume posted last year of 0.11 million. As of the previous 9 days, the stock’s Stochastic %D was 78.72%.
During the past 100 days, RAPT Therapeutics Inc’s (RAPT) raw stochastic average was set at 71.72%, which indicates a significant increase from 71.21% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.88 in the past 14 days, which was higher than the 0.84 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.89, while its 200-day Moving Average is $10.10. Now, the first resistance to watch is $12.02. This is followed by the second major resistance level at $13.43. The third major resistance level sits at $14.92. If the price goes on to break the first support level at $9.12, it is likely to go to the next support level at $7.63. Now, if the price goes above the second support level, the third support stands at $6.22.
RAPT Therapeutics Inc (NASDAQ: RAPT) Key Stats
The company with the Market Capitalisation of 175.44 million has total of 16,536K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -129,870 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -17,170 K.